Related Experiment Video
Updated: Jun 19, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Brain tumor survivors speak out
1Children's Hospitals & Clinics of Minnesota, Psychological Services 62-200, 360 Sheridan Street, Saint Paul, MN 55102, USA. bonnie.carlson-green@childrensmn.org
Summary
Adult survivors of childhood brain tumors face challenges in social/emotional adjustment, neurocognitive late effects, and employment. This study offers guidelines to improve outcomes for these survivors.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Survivorship Research
Background:
- Childhood brain tumors require ongoing research for improved patient outcomes.
- Individual differences in outcomes necessitate understanding disease, treatment, and contextual factors.
- Survivors often face long-term challenges impacting quality of life.
Purpose of the Study:
- To review key concerns for childhood brain tumor survivors.
- To integrate survivor perspectives with existing literature.
- To provide guidelines for healthcare professionals to enhance survivor care.
Main Methods:
- Combined idiographic (survivor observations) and nomothetic (literature review) approaches.
- Reviewed literature on brain tumor and childhood cancer survivors.
- Focused on six critical areas: social/emotional adjustment, insurance, neurocognitive late effects, sexuality, employment, and information access.
Main Results:
- Identified significant concerns across social/emotional, neurocognitive, and vocational domains.
- Highlighted survivor experiences regarding information access and insurance.
- Synthesized idiographic and nomothetic data to inform recommendations.
Conclusions:
- Childhood brain tumor survivorship requires a comprehensive approach addressing multiple life domains.
- Guidelines are proposed to improve psychosocial and neurocognitive outcomes.
- Healthcare professionals can utilize these guidelines to better support survivors.
Related Concept Videos
01:28Traumatic Brain Injury l: Introduction
DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...